Education
About Us
Working with TipRanks
Follow Us
Vireo Growth (VREOF)
OTHER OTC:VREOF
VREOF Stock Chart & Stats
$0.63
$0.02(3.15%)
At close: 4:00 PM EST
$0.63
$0.02(3.15%)
Day’s Range― - ―
52-Week Range$0.24 - $0.80
Previous CloseN/A
Volume345.43K
Average Volume (3M)192.61K
Market Cap
$673.17M
Enterprise Value$404.70M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.24
Next Earnings
Mar 05, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,038,706,700
10 Day Avg. Volume100,700
30 Day Avg. Volume192,613
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.60
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vireo Growth News
VREOF FAQ
What was Vireo Growth’s price range in the past 12 months?
Vireo Growth lowest stock price was $0.24 and its highest was $0.80 in the past 12 months.
What is Vireo Growth’s market cap?
Vireo Growth’s market cap is $673.17M.
When is Vireo Growth’s upcoming earnings report date?
Vireo Growth’s upcoming earnings report date is Mar 05, 2026 which is in 77 days.
How were Vireo Growth’s earnings last quarter?
Vireo Growth released its earnings results on Nov 12, 2025. The company reported -$0.019 earnings per share for the quarter, missing the consensus estimate of $0.01 by -$0.029.
Is Vireo Growth overvalued?
According to Wall Street analysts Vireo Growth’s price is currently Overvalued.
Does Vireo Growth pay dividends?
Vireo Growth does not currently pay dividends.
What is Vireo Growth’s EPS estimate?
Vireo Growth’s EPS estimate is 0.01.
How many shares outstanding does Vireo Growth have?
Vireo Growth has 1,038,706,700 shares outstanding.
What happened to Vireo Growth’s price movement after its last earnings report?
Vireo Growth reported an EPS of -$0.019 in its last earnings report, missing expectations of $0.01. Following the earnings report the stock price went down -3.448%.
Which hedge fund is a major shareholder of Vireo Growth?
Currently, no hedge funds are holding shares in VREOF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vireo Growth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.17%
12-Months-Change
Fundamentals
Return on Equity
-34.20%
Trailing 12-Months
Asset Growth
238.68%
Trailing 12-Months
Company Description
Vireo Growth
Vireo Health International, Inc. is a holding company, which engages in the cultivation, production, and sale of medical cannabis. Its products include medical marijuana extracts in the form of oils, vaporizers, and capsules. The company was founded on November 23, 2004 and is headquartered in Minneapolis, MN.
VREOF Company Deck
VREOF Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected strong revenue growth and successful refinancing efforts, improving cash flow and operational efficiency. However, challenges with gross margin, uncertainty in Minnesota's expansion, and regulatory delays in New York asset sales presented notable concerns.View all VREOF earnings summariesTechnical Analysis
ZYUS Life Sciences
―
MTL Cannabis
―
Leef Brands
―
Refined Energy
―
Simply Solventless Concentrates Ltd
―
Ownership Overview
Options Prices
Currently, No data available
---